In diabetic foot infections antibiotics are to treat infection, not to heal wounds

Bibliography

• Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-93
   PubMed Web of Science ®Google Scholar
• Tsourdi E, Barthel A, Rietzsch H, et al. Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus. Biomed Res Int 2013;2013:385641
   PubMed Web of Science ®Google Scholar
• Darbellay P, Uçkay I, Dominguez D, et al. Diabetic foot infection: a multidisciplinary approach. Rev Med Suisse 2011;7:894-7
   PubMedGoogle Scholar
• White R, McIntosh C. Topical therapies for diabetic foot ulcers: standard treatments. J Wound Care 2008;17:426, 428-32
   Google Scholar
• Lipsky BA, Berendt A, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132-73
   Google Scholar
• Cunha BA. Antibiotic side effects. Med Clin North Am 2001;85:149-85
   PubMed Web of Science ®Google Scholar
• Bell M. Antibiotic misuse: a global crisis. JAMA Intern Med 2014;174:1920-1
   PubMedGoogle Scholar
• Gottrup F, Apelqvist J, Bjarnsholt T, et al. EWMA document: antimicrobials and non-healing wounds. Evidence, controversies and suggestions. J Wound Care 2013;22:S1-89
   Web of Science ®Google Scholar
• Dezfulian A, Aslani MM, Oskoui M, et al. Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iran J Basic Med Sci 2012;15:803-6
   PubMed Web of Science ®Google Scholar
• Tascini C, Gemignani G, Palumbo F, et al. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis. J Chemother 2006;18:648-51
   PubMed Web of Science ®Google Scholar
• Kavitha KV, Tiwari S, Purandare VB, et al. Choice of wound care in diabetic foot ulcer: a practical approach. World J Diabetes 2014;5:546-56
   PubMedGoogle Scholar
• Siavash M, Shokri S, Haghighi S, et al. The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial. Int Wound J 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008;47:1537-45
   PubMed Web of Science ®Google Scholar
• Mutluoglu M, Uzun G, Yildiz S. Hyperbaric oxygen therapy in the treatment of diabetic foot ulcers–prudent or problematic: a case report. Ostomy Wound Manage 2010;56:32-5
   PubMedGoogle Scholar
• Landsman A, Blume PA, Jordan DA, et al. An open-label, three-arm pilot study of the safety and efficacy of topical Microcyn Rx wound care versus oral levofloxacin versus combined therapy for mild diabetic foot infections. J Am Podiatr Med Assoc 2011;101:484-96
   PubMedGoogle Scholar
• Mayser P, Freund V, Budihardja D. Toenail onychomycosis in diabetic patients: issues and management. Am J Clin Dermatol 2009;10:211-20
   PubMed Web of Science ®Google Scholar
• Melamed EA, Peled E. Antibiotic impregnated cement spacer for salvage of diabetic osteomyelitis. Foot Ankle Int 2012;33:213-19
   PubMedGoogle Scholar
• Salgami EV, Bowling FL, Whitehouse RW, et al. Use of tobramycin-impregnated calcium sulphate pellets in addition to oral antibiotics: an alternative treatment to minor amputation in a case of diabetic foot osteomyelitis. Diabetes Care 2007;30:181-2
   PubMedGoogle Scholar
• Mendes JJ, Leandro C, Corte-Real S, et al. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 2013;21:595-603
   PubMed Web of Science ®Google Scholar
• Bowling FL, Salgami E V, Boulton AJM. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007;30:370-1
   PubMedGoogle Scholar
• Lázaro-Martínez JL, Aragón-Sánchez J, García-Morales E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care 2014;37:789-95
   PubMed Web of Science ®Google Scholar
• Aragón-Sánchez J, Lázaro-Martínez JL, Alvaro-Afonso FJ, et al. Conservative surgery of diabetic forefoot osteomyelitis: how can I operate on this patient without amputation? Int J Low Extrem Wounds 2014. [Epub ahead of print]
   Google Scholar
• Mannucci E, Genovese S, Monami M, et al. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study-the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study. Acta Diabetol 2013;51:435-40
   PubMedGoogle Scholar
• Tobalem M, Uçkay I. Images in clinical medicine. Evolution of a diabetic foot infection. N Engl J Med 2013;369:2252
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999;26:267-76
   PubMedGoogle Scholar
• Lipsky BA. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis 2008;47:528-30
   PubMed Web of Science ®Google Scholar
• Bernard L, Assal M, Garzoni C, Uçkay I. Predicting the pathogen of diabetic toe osteomyelitis by two consecutive ulcer cultures with bone contact. Eur J Clin Microbiol Infect Dis 2011;30:279-81
   PubMedGoogle Scholar
• Tian M, Jiang Y-Z, Niu Y-W, et al. A severely infected diabetic foot treated successfully without using systemic antibiotics. Int J Low Extrem Wounds 2012;11:296-8
   PubMedGoogle Scholar
• Dalla Paola L, Faglia E. Treatment of diabetic foot ulcer: an overview strategies for clinical approach. Curr Diabetes Rev 2006;2:431-47
   PubMedGoogle Scholar
• Ruth Chaytor E. Surgical treatment of the diabetic foot. Diabetes Metab Res Rev 2000;16(Suppl 1):S66-9
   Google Scholar
• Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004;39(Suppl 2):S115-22
   PubMed Web of Science ®Google Scholar
• Tone A, Nguyen S, Devemy F, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 2015;38:302-7
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question? Diabetes Care 2014;37:593-5
   PubMed Web of Science ®Google Scholar
• Ambrosch A, Halevy D, Fwity B, et al. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot. Int J Low Extrem Wounds 2014;13:12-16
   PubMedGoogle Scholar
• Chantelau E, Tanudjaja T, Altenhöfer F, et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996;13:156-9
   PubMed Web of Science ®Google Scholar
• Hirschl M, Hirschl AM. Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone. Chemotherapy 1992;38:275-80
   PubMedGoogle Scholar
• Zhang M, Jiang Z, Li D, et al. Oral Antibiotic Treatment Induces Skin Microbiota Dysbiosis and Influences Wound Healing. Microb Ecol 2014;69(2):415-21
   PubMedGoogle Scholar
• Patterson JE. Antibiotic utilization: is there an effect on antimicrobial resistance? Chest 2001;119(2 Suppl):426S-30S
   Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87
   PubMed Web of Science ®Google Scholar
• Van De Sande-Bruinsma N, Grundmann H, Verloo D, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008;14:1722-30
   PubMed Web of Science ®Google Scholar
• Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect 2009;15:12-15
   PubMed Web of Science ®Google Scholar
• Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004;9:S6-15
   PubMedGoogle Scholar
• Xu L, McLennan S V, Lo L, et al. Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007;30:378-80
   PubMed Web of Science ®Google Scholar
• Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ostomy Wound Manage 2001;47:44-9
   PubMedGoogle Scholar
• James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44
   PubMed Web of Science ®Google Scholar
• O’Meara S, Al-Kurdi D, Ologun Y, et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014;1:CD003557
   Google Scholar
• Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003;361:1545-51
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 2012;28(Suppl 1):163-78
   PubMed Web of Science ®Google Scholar
• Leese G, Nathwani D, Young M, et al. Use of antibiotics in people with diabetic foot disease: a consensus statement. Diabetic Foot J 2009;12(2):62-74
   Google Scholar
• Petursson P. GPs’ reasons for “non-pharmacological” prescribing of antibiotics. A phenomenological study. Scand J Prim Health Care 2005;23:120-5
   PubMed Web of Science ®Google Scholar
• Oien RF, Forssell HW. Ulcer healing time and antibiotic treatment before and after the introduction of the Registry of Ulcer Treatment: an improvement project in a national quality registry in Sweden. BMJ Open 2013;3:e003091
   PubMed Web of Science ®Google Scholar
• Grover ML, Nordrum JT, Mookadam M, et al. Addressing antibiotic use for acute respiratory tract infections in an academic family medicine practice. Am J Med Qual 2013;28:485-91
   PubMedGoogle Scholar
• Vinnard C, Linkin DR, Localio AR, et al. Effectiveness of interventions in reducing antibiotic use for upper respiratory infections in ambulatory care practices. Popul Health Manag 2013;16:22-7
   PubMed Web of Science ®Google Scholar
• Percival SL, Vuotto C, Donelli G, et al. Biofilms and wounds: an identification algorithm and potential treatment options. Adv Wound Care 2014. [Epub ahead of print]
   Google Scholar
• Percival SL, Hill KE, Williams DW, et al. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012;20:647-57
   PubMed Web of Science ®Google Scholar
• Malik A, Mohammad Z, Ahmad J. The diabetic foot infections: biofilms and antimicrobial resistance. Diabetes Metab Syndr 2013;7:101-7
   PubMedGoogle Scholar
• Uçkay I, Pittet D, Vaudaux P, et al. Foreign body infections due to Staphylococcus epidermidis. Ann Med 2009;41:109-19
   PubMed Web of Science ®Google Scholar
• Gawande P V, Leung KP, Madhyastha S. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria. Curr Microbiol 2014;68:635-41
   PubMedGoogle Scholar
• Ammons MC, Copié V. Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 2013;29:443-55
   PubMed Web of Science ®Google Scholar
• Uçkay I, Hoffmeyer P, Lew D, Pittet D. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. J Hosp Infect 2013;84:5-12
   PubMed Web of Science ®Google Scholar
• Seghrouchni K, van Delden C, Dominguez D, et al. Remission after treatment of osteoarticular infections due to Pseudomonas aeruginosa versus Staphylococcus aureus: a case-controlled study. Int Orthop 2012;36:1065-71
   PubMed Web of Science ®Google Scholar
• Uçkay I, Teterycz D, Ferry T, et al. Poor utility of MRSA screening to predict staphylococcal species in orthopaedic implant infections. J Hosp Infect 2009;73:89-91
   PubMed Web of Science ®Google Scholar
• Zenelaj B, Bouvet C, Lipsky BA, Uçkay I. Do Diabetic Foot Infections With Methicillin-Resistant Staphylococcus aureus Differ From Those With Other Pathogens? Int J Low Extrem Wounds 2014;13:263-72
   PubMed Web of Science ®Google Scholar
• Post V, Wahl P, Uçkay I, et al. Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections. Int J Med Microbiol 2014;304:565-76
   PubMed Web of Science ®Google Scholar
• Nelson EA, O’Meara S, Golder S, et al. Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006;23:348-59
   PubMed Web of Science ®Google Scholar
• Selva Olid A, Barajas-Nava LA, Gianneo OD, et al. Systemic antibiotics for treating diabetic foot infections (Protocol). Cochrane Database Syst Rev 2011;4:Art. No.: CD009061
   Google Scholar
• Lipsky BA, Hoey C, Cruciani M, et al. Topical antimicrobial agents for preventing and treating foot infections in people with diabetes. Cochrane Database Syst Rev 2014;Art. No.: CD011038
   Google Scholar
• Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab 2014;16:305-16
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 2007;13:351-3
   PubMed Web of Science ®Google Scholar
• Nelson EA, Backhouse MR, Bhogal MS, et al. Concordance in diabetic foot ulcer infection. BMJ Open 2013;3:1-8
   Google Scholar
• Lipsky BA, Kuss M, Edmonds M, et al. Topical Application of a Gentamicin-Collagen Sponge Combined with Systemic Antibiotic Therapy for the Treatment of Diabetic Foot Infections of Moderate Severity. J Am Podiatr Med Assoc 2012;102:223-32
   PubMed Web of Science ®Google Scholar
• Varga M, Sixta B, Bem R, et al. Application of gentamicin-collagen sponge shortened wound healing time after minor amputations in diabetic patients - A prospective, randomised trial. Arch Med Sci 2014;10:283-7
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009;49:1541-9
   PubMed Web of Science ®Google Scholar
• Reber A, Moldovan A, Dunkel N, et al. Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections? J Infect 2012;64:513-19
   PubMed Web of Science ®Google Scholar
• Diehr S, Hamp A, Jamieson B, Mendoza M. Clinical inquiries. Do topical antibiotics improve wound healing? J Fam Pract 2007;56:140-4
   PubMedGoogle Scholar
• Gariani K, Uçkay I, Lipsky BA. Managing diabetic foot infections: a review of the new guidelines. Acta Chir Belg 2014;114:7-16
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Pecoraro RE, Larson SA, et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150:790-7
   PubMedGoogle Scholar
• Diamantopoulos EJ, Haritos D, Yfandi G, et al. Management and outcome of severe diabetic foot infections. Exp Clin Endocrinol Diabetes 1998;106:346-52
   PubMed Web of Science ®Google Scholar
• Pittet D, Wyssa B, Herter-Clavel C, et al. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 1999;159:851-6
   PubMedGoogle Scholar
• Senneville E, Lombart A, Beltrand E, et al. Outcome of diabetic foot osteomyelitis treated nonsurgically. Diabetes Care 2008;31:637-42
   PubMed Web of Science ®Google Scholar
• Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001;48:927-30
   PubMed Web of Science ®Google Scholar
• Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008;51:962-7
   PubMed Web of Science ®Google Scholar
• Acharya S, Soliman M, Egun A, Rajbhandari SM. Conservative management of diabetic foot osteomyelitis. Diabetes Res Clin Pract 2013;101:e18-20
   PubMed Web of Science ®Google Scholar
• Bogner JR, Kutaiman A, Esguerra-Alcalen M, et al. Moxifloxacin in complicated skin and skin structure infections (cSSSIs): a prospective, international, non-interventional, observational study. Adv Ther 2013;30:630-43
   PubMedGoogle Scholar
• Conterno LO, Turchi MD. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2013;9:CD004439
   Google Scholar
• Grayson ML, Gibbons GW, Habershaw GM, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Baker PD, Landon GC, Fernau R. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997;24:643-8
   PubMed Web of Science ®Google Scholar
• Clay PG, Graham MR, Lindsey CC, et al. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older mal. Am J Geriatr Pharmacother 2004;2:181-9
   PubMedGoogle Scholar
• Lipsky BA, Itani K, Norden C. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004;38:17-24
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Armstrong DG, Citron DM, et al. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005;366:1695-703
   PubMed Web of Science ®Google Scholar
• Lipsky BA Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother 2005;55:240-5
   PubMedGoogle Scholar
• Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect 2005;6:27-40
   PubMedGoogle Scholar
• Embil JM, Soto NE, Melnick DA. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus. Clin Ther 2006;28:1164-74
   PubMedGoogle Scholar
• Lipsky BA, Giordano P, Choudhri S, et al. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother 2007;60:370-6
   PubMed Web of Science ®Google Scholar
• Vick-Fragoso R, Hernández-Oliva G, Cruz-Alcázar J, et al. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 2009;37:407-17
   PubMed Web of Science ®Google Scholar
• Saltoglu N, Dalkiran A, Tetiker T, et al. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect 2010;16:1252-7
   PubMed Web of Science ®Google Scholar
• Schaper NC, Dryden M, Kujath P, et al. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. Infection 2013;41:175-86
   PubMed Web of Science ®Google Scholar
• Lauf L, Ozsvár Z, Mitha I, et al. Phase III study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis. Diagn Microbiol Infect Dis 2014;78:469-80
   PubMed Web of Science ®Google Scholar
• Citron DM, Goldstein EJC, Merriam CV, et al. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007;45:2819-28
   PubMed Web of Science ®Google Scholar
• Peterson LR, Lissack LM, Canter K, et al. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989;86:801-8
   PubMed Web of Science ®Google Scholar
• Embil JM, Rose G, Trepman E, et al. Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 2006;27:771-9
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Cannon CM, Ramani A, et al. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Diabetes Metab Res Rev 2014. [Epub ahead of print]
   Google Scholar